Impact Biomedical (IBO) Inventory (2025 - 2026)
Impact Biomedical (IBO) posted Inventory of $63000.0 for Q1 2026, little changed on a QoQ basis from $63000.0 in Q4 2025, and down 87.12% year-over-year from $489000.0 in Q1 2025.
Impact Biomedical (IBO) Inventory (2025 - 2026) Analysis & Trends
Impact Biomedical's Inventory history runs 2 years deep, the most recent figure standing at $63000.0 for Q1 2026.
- Quarterly Inventory fell 87.12% year-over-year to $63000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63000.0 (down 87.12% YoY) and the FY2025 annual result came in at $63000.0, changed N/A from the prior year.
- Inventory was $63000.0 for Q1 2026 at Impact Biomedical, roughly flat from $63000.0 in the prior quarter.
- Across five years, Inventory topped out at $489000.0 in Q1 2025 and bottomed at $63000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 681.59 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.77 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.10 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 371.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 485,000.00 |
| Jun 30, 2025 | 486,000.00 |
| Mar 31, 2025 | 489,000.00 |